The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A blood-based epigenetic test for early detection of nasopharyngeal carcinoma (NPC).
Yew-Oo Tan
No relevant relationships to disclose
Eduard M. Alfanta
No relevant relationships to disclose
Ramon Antonio B. Lopa
No relevant relationships to disclose
Elaine Hsuen Lim
No relevant relationships to disclose
Hwee Yong Whang
Employment or Leadership Position - Epitech International
Stock Ownership - Epitech International
Karmen Wong
No relevant relationships to disclose
Philip Jordan
Employment or Leadership Position - Oxford Biodynamics
Stock Ownership - Oxford Biodynamics
Emily Corfield
Employment or Leadership Position - Oxford Biodynamics
Matthew Salter
Employment or Leadership Position - Oxford Biodynamics
Megan Field
Employment or Leadership Position - Oxford Biodynamics
Alexandre Akoulitchev
Employment or Leadership Position - Oxford Biodynamics
Stock Ownership - Oxford Biodynamics
Thomas Kwok Seng Loh
No relevant relationships to disclose
Boon C. Goh
No relevant relationships to disclose
Wen Son Hsieh
Employment or Leadership Position - Epitech International
Stock Ownership - Epitech International